What question did this study set out to answer?

The research aims to identify new modulators of glucokinase regulatory protein and assess their potential as antidiabetic agents.

Targeting the Glucokinase–Glucokinase Regulatory Protein Axis: Pharmacophore-Based Identification of Novel Antidiabetic Small Molecules

View Full Paper

Ask AI

Bookmark

Authors

Pharmacophore-based identification of novel antidiabetic agents shows promise in diabetes treatment.

The research aims to identify new modulators of glucokinase regulatory protein and assess their potential as antidiabetic agents.
Developed pharmacophore models using Hypogen and HipHop methodologies.
Conducted virtual screening of the NCI database for potential GKRP modulators.
Performed docking studies and in vitro assays to evaluate binding and efficacy of identified compounds.
Conducted in vivo experiments to assess metabolic improvements and tissue restoration.
Analyzed gene expression related to glucose metabolism and inflammation.
Identified compounds NCS 1972 and NCS 80683 as key hits with significant binding to GKRP.
NCS 1972 showed an IC50 of 1.60 nM and improved lipid profiles and reduced liver hypertrophy in vivo.
Histopathological analysis indicated substantial cellular restoration in pancreatic and liver tissues with NCS 1972.
Both compounds corrected dysregulated glucose metabolism and inflammatory markers due to HFD-STZ.

Paliwal et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark